Cochlear (CHEOF) Stock Price, News & Analysis

Company Overview

Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.

Key Stats

• Today's Range: $177.28 to $177.28
• 50-Day Range: $148.62 to $180.72
• 52-Week Range: $148.62 to $237.38
• Volume: N/A
• Average Volume: 125 shs
• Market Capitalization: N/A
• P/E Ratio: 107.97
• Dividend Yield: 0.72%
• Price Target: N/A
• Consensus Rating: N/A

Cochlear Stock Analysis - MarketRank™

Cochlear scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Cochlear.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Cochlear is 107.97, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.68.

Price to Earnings Ratio vs. Sector

The P/E ratio of Cochlear is 107.97, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.39.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cochlear has a short interest ratio ("days to cover") of 62, which indicates bearish sentiment.

Change versus previous month

Short interest in Cochlear has recently decreased by 6.94%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Cochlear pays a meaningful dividend of 2.07%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Cochlear does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Cochlear is 77.34%. Payout ratios above 75% are not desirable because they may not be sustainable.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Cochlear has a short interest ratio ("days to cover") of 62, which indicates bearish sentiment.

Change versus previous month

Short interest in Cochlear has recently decreased by 6.94%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Cochlear this week, compared to 2 articles on an average week.

MarketBeat Follows

2 people have added Cochlear to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Cochlear insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 22.47% of the stock of Cochlear is held by institutions.

CHEOF Stock Analysis - Frequently Asked Questions

How have CHEOF shares performed this year?

Cochlear's stock was trading at $182.0528 at the beginning of 2025. Since then, CHEOF shares have decreased by 2.6% and is now trading at $177.28.
View the best growth stocks for 2025 here.

How do I buy shares of Cochlear?

Shares of CHEOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CHEOF
• CIK: 1453930
• Web: www.cochlear.com
• Phone: (129) 428-6555
• Fax: N/A
• Employees: 4,800
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 107.97
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A